These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21677890)

  • 1. Early start of chemotherapy after resection of primary colon cancer with synchronous multiple liver metastases: a case report.
    Yoshida Y; Hoshino S; Shiwaku H; Beppu R; Tanimura S; Tanaka S; Yamashita Y
    Case Rep Oncol; 2011 May; 4(2):250-4. PubMed ID: 21677890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early start of chemotherapy after resection of brain metastasis from colon cancer with synchronous multiple liver metastases.
    Yoshida Y; Hoshino S; Miyake T; Fukuda S; Yamada K; Naoya A; Tanimura S; Yamashita Y
    Case Rep Oncol; 2012 May; 5(2):290-5. PubMed ID: 22740818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of the early start of chemotherapy after resection of primary colorectal cancer with distant metastases (Pearl Star 01).
    Yoshida Y; Hoshino S; Aisu N; Naito M; Miyake T; Tanimura S; Yamashita Y
    World J Surg Oncol; 2013 Feb; 11():39. PubMed ID: 23388092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.
    Rothenberg ML; Cox JV; Butts C; Navarro M; Bang YJ; Goel R; Gollins S; Siu LL; Laguerre S; Cunningham D
    Ann Oncol; 2008 Oct; 19(10):1720-6. PubMed ID: 18550577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer.
    Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS
    Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of colorectal liver metastases.
    Ismaili N
    World J Surg Oncol; 2011 Nov; 9():154. PubMed ID: 22115124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.
    Cassidy J; Clarke S; Díaz-Rubio E; Scheithauer W; Figer A; Wong R; Koski S; Lichinitser M; Yang TS; Rivera F; Couture F; Sirzén F; Saltz L
    J Clin Oncol; 2008 Apr; 26(12):2006-12. PubMed ID: 18421053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Successfully Resected Case of Recurrent Lung and Liver Metastases of Rectal Cancer Treated with XELIRI + Bevacizumab Therapy.
    Aisu N; Yoshida Y; Ishii F; Miyake T; Tanimura S; Wada Y; Yamauchi Y; Hoshino S; Noritomi T; Yamashita Y
    Case Rep Oncol; 2013 Jan; 6(1):143-7. PubMed ID: 23569449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study on early start of chemotherapy after excising primary colorectal cancer with distant metastases (Pearl Star 02).
    Yoshida Y; Aisu N; Kojima D; Mera T; Kiyomi F; Yamashita Y; Hasegawa S
    Ann Gastroenterol Surg; 2017 Sep; 1(3):219-225. PubMed ID: 29863132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Partial Chromosomal Instability With Chemotherapeutically Resistant Metachronous Colorectal Cancer Following a Synchronous Primary Colorectal Cancer: A Case Report.
    Dominic JL; Feroz SH; Muralidharan A; Ahmed A; Thirunavukarasu P
    Cureus; 2020 Nov; 12(11):e11308. PubMed ID: 33282585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of first-line combination chemotherapy in advanced colorectal cancer: a Korean single-center experience.
    Lee S; Park SH; Lim DH; Park KW; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Cancer Res Treat; 2011 Jun; 43(2):96-101. PubMed ID: 21811425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
    Muro K; Boku N; Shimada Y; Tsuji A; Sameshima S; Baba H; Satoh T; Denda T; Ina K; Nishina T; Yamaguchi K; Takiuchi H; Esaki T; Tokunaga S; Kuwano H; Komatsu Y; Watanabe M; Hyodo I; Morita S; Sugihara K
    Lancet Oncol; 2010 Sep; 11(9):853-60. PubMed ID: 20708966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
    Jonker D; Rumble RB; Maroun J;
    Curr Oncol; 2006 Oct; 13(5):173-84. PubMed ID: 22792014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.
    Moreau LC; Rajan R; Thirlwell MP; Alcindor T
    Anticancer Res; 2013 Apr; 33(4):1765-8. PubMed ID: 23564831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
    Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
    Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
    Satake H; Hashida H; Tanioka H; Miyake Y; Yoshioka S; Watanabe T; Matsuura M; Kyogoku T; Inukai M; Kotake T; Okita Y; Matsumoto T; Yasui H; Kotaka M; Kato T; Kaihara S; Tsuji A
    Oncologist; 2021 Jul; 26(7):e1125-e1132. PubMed ID: 33977607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer.
    Ducreux M; Bennouna J; Hebbar M; Ychou M; Lledo G; Conroy T; Adenis A; Faroux R; Rebischung C; Bergougnoux L; Kockler L; Douillard JY;
    Int J Cancer; 2011 Feb; 128(3):682-90. PubMed ID: 20473862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staged Double Hepatectomy, Double Total Vascular Exclusion, and Double Venous Reconstruction by Peritoneal Patches in One Patient with Colorectal Liver Metastases.
    Dokmak S; Aussilhou B; Levenson G; Guarneri G; Soubrane O
    Ann Surg Oncol; 2021 Apr; 28(4):2028-2029. PubMed ID: 32968956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.